FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3112919784> ?p ?o ?g. }

• W3112919784 endingPage "18" @default.
• W3112919784 startingPage "1" @default.
• W3112919784 abstract "Purpose. Mucopolysaccharidoses (MPS) are group of inherited lysosomal storage diseases caused by mutations of enzymes involved in catalyzing different glycosaminoglycans (GAGs). MPS I and MPS II exhibit both somatic and neurological symptoms with a relatively high disease incidence. Hematopoietic stem cell therapy (HSCT) and intravenous enzyme replacement therapy (ERT) have had a significant impact on the treatment and comprehension of disease. This review is aimed at providing a comprehensive evaluation of the pros and cons of HSCT and ERT, as well as an up-to-date knowledge of new drugs under development. In addition, multiple disease management strategies for the uncontrollable manifestations of MPS I and MPS II to improve patients’ quality of life are presented. Findings. Natural history of MPS I and MPS II shows that somatic and neurological symptoms occur earlier in severe forms of MPS I than in MPS II. ERT increases life expectancy and alleviates some of the somatic symptoms, but musculoskeletal, ophthalmological, and central nervous system (CNS) manifestations are not controlled. Additionally, life-long treatment burdens and immunogenicity restriction are unintended consequences of ERT application. HSCT, another treatment method, is effective in controlling the CNS symptoms and hence has been adopted as the standard treatment for severe types of MPS I. However, it is ineffective in MPS II, which can be explained by the relatively late diagnosis. In addition, several factors such as transplant age limits or graft-versus-host disease in HSCT have limited its application for patients. Novel therapies, including BBB-penetrable-ERT, gene therapy, and substrate reduction therapy, are under development to control currently unmanageable manifestations. BBB-penetrable-ERT is being studied comprehensively in the hopes of being used in the near future as a method to effectively control CNS symptoms. Gene therapy has the potential to “cure” the disease with a one-time treatment rather than just alleviate symptoms, which makes it an attractive treatment strategy. Several clinical studies on gene therapy reveal that delivering genes directly into the brain achieves better results than intravenous administration in patients with neurological symptoms. Considering new drugs are still in clinical stage, disease management with close monitoring and supportive/palliative therapy is of great importance for the time being. Proper rehabilitation therapy, including physical and occupational therapy, surgical intervention, or medications, can benefit patients with uncontrolled musculoskeletal, respiratory, ophthalmological, and neurological manifestations." @default.
• W3112919784 created "2020-12-21" @default.
• W3112919784 creator A5051665159 @default.
• W3112919784 creator A5086560709 @default.
• W3112919784 creator A5090369700 @default.
• W3112919784 date "2020-12-04" @default.
• W3112919784 modified "2023-10-11" @default.
• W3112919784 title "Mucopolysaccharidoses I and II: Brief Review of Therapeutic Options and Supportive/Palliative Therapies" @default.
• W3112919784 cites W1418744509 @default.
• W3112919784 cites W1493161648 @default.
• W3112919784 cites W1505579668 @default.
• W3112919784 cites W1520200254 @default.
• W3112919784 cites W1528233954 @default.
• W3112919784 cites W1552129388 @default.
• W3112919784 cites W1598400863 @default.
• W3112919784 cites W1603450504 @default.
• W3112919784 cites W1771887010 @default.
• W3112919784 cites W1967355953 @default.
• W3112919784 cites W1973635706 @default.
• W3112919784 cites W1974362847 @default.
• W3112919784 cites W1977288797 @default.
• W3112919784 cites W1983308625 @default.
• W3112919784 cites W1983469525 @default.
• W3112919784 cites W1985211153 @default.
• W3112919784 cites W1985433665 @default.
• W3112919784 cites W1987251162 @default.
• W3112919784 cites W1987700120 @default.
• W3112919784 cites W1988242870 @default.
• W3112919784 cites W1993583886 @default.
• W3112919784 cites W1994060660 @default.
• W3112919784 cites W1995821770 @default.
• W3112919784 cites W1997831257 @default.
• W3112919784 cites W1999330037 @default.
• W3112919784 cites W1999431438 @default.
• W3112919784 cites W2000413207 @default.
• W3112919784 cites W2001489265 @default.
• W3112919784 cites W2007961606 @default.
• W3112919784 cites W2008017490 @default.
• W3112919784 cites W2011313278 @default.
• W3112919784 cites W2012856015 @default.
• W3112919784 cites W2014241746 @default.
• W3112919784 cites W2019263584 @default.
• W3112919784 cites W2020091043 @default.
• W3112919784 cites W2024990739 @default.
• W3112919784 cites W2026477204 @default.
• W3112919784 cites W2027292988 @default.
• W3112919784 cites W2030834145 @default.
• W3112919784 cites W2042067606 @default.
• W3112919784 cites W2043754477 @default.
• W3112919784 cites W2043941872 @default.
• W3112919784 cites W2045134661 @default.
• W3112919784 cites W2050180123 @default.
• W3112919784 cites W2052314207 @default.
• W3112919784 cites W2052326484 @default.
• W3112919784 cites W2052820865 @default.
• W3112919784 cites W2057594413 @default.
• W3112919784 cites W2058795042 @default.
• W3112919784 cites W2059934840 @default.
• W3112919784 cites W2064374974 @default.
• W3112919784 cites W2068247176 @default.
• W3112919784 cites W2071543365 @default.
• W3112919784 cites W2072319599 @default.
• W3112919784 cites W2075219974 @default.
• W3112919784 cites W2075495923 @default.
• W3112919784 cites W2076191063 @default.
• W3112919784 cites W2078270939 @default.
• W3112919784 cites W2080567909 @default.
• W3112919784 cites W2081560552 @default.
• W3112919784 cites W2087050432 @default.
• W3112919784 cites W2091208982 @default.
• W3112919784 cites W2093722439 @default.
• W3112919784 cites W2103457363 @default.
• W3112919784 cites W2105688742 @default.
• W3112919784 cites W2106256529 @default.
• W3112919784 cites W2108835452 @default.
• W3112919784 cites W2109407008 @default.
• W3112919784 cites W2109957082 @default.
• W3112919784 cites W2110978695 @default.
• W3112919784 cites W2114566908 @default.
• W3112919784 cites W2115034909 @default.
• W3112919784 cites W2117500144 @default.
• W3112919784 cites W2119181048 @default.
• W3112919784 cites W2121882313 @default.
• W3112919784 cites W2123587476 @default.
• W3112919784 cites W2127291738 @default.
• W3112919784 cites W2131656339 @default.
• W3112919784 cites W2132081940 @default.
• W3112919784 cites W2132481477 @default.
• W3112919784 cites W2135171532 @default.
• W3112919784 cites W2135707088 @default.
• W3112919784 cites W2137890611 @default.
• W3112919784 cites W2138335140 @default.
• W3112919784 cites W2148584888 @default.
• W3112919784 cites W2151879267 @default.
• W3112919784 cites W2158466604 @default.
• W3112919784 cites W2159823307 @default.
• W3112919784 cites W2160708072 @default.
• W3112919784 cites W2161110724 @default.

• next